Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B‐cell lymphoma, leg type. (30th September 2019) - Di Raimondo, Cosimo; Abdulla, Farah R.; Zain, Jasmine; Querfeld, Christiane; Rosen, Steven T.